Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
CombiPatch® (estradiol/norethindrone acetate transdermal system) Rx only Prescribing Information
Medication labelWhy this: Advisory · dailymed-prescription
CombiPatch is indicated in a woman with a uterus for: Treatment of moderate to severe vasomotor symptoms due to menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure.
- generic_name
- estradiol/norethindrone acetate transdermal system
- product_names
- estradiol/norethindrone acetate transdermal system
- ndc
- 68968-0514, 68968-0525, 68968-0514-8, 68968-0525-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en